[Clinical characteristics of 29 cases of pulmonary mucormycosis treated with and without surgery]

Zhonghua Jie He He Hu Xi Za Zhi. 2024 Oct 12;47(10):946-954. doi: 10.3760/cma.j.cn112147-20240426-00223.
[Article in Chinese]

Abstract

Objective: To analyze the clinical characteristics of patients with pulmonary mucormycosis treated with and without surgery. Methods: This was a single-center, retrospective study. We retrieved "pulmonary mucormycosis" from the electronic medical records of China-Japan Friendship Hospital between 2016 and 2022. A total of 29 patients with pulmonary mucormycosis were collected. There were 19 males and 10 females with a median age of 49 (47, 67) years. Mann-Whitney U test, χ² test, Kaplan-Meier curve and log-rank test were used to compare the differences between groups. Results: The most common underlying disease was diabetes (19, 65.5%). The most frequent imaging findings were consolidation (25, 86.2%) and nodule or mass (21, 72.4%). Bronchial stenosis (16, 55.2%), obstruction by fungal plugs (18, 62.1%), pseudomembranous necrotizing bronchitis (19, 65.5%) were common. Treatment strategies were developed by the multi-disciplinary team (MDT). Among 16 patients who did not undergo surgery, 10 had bilateral multifocal lesions and 6 had unifocal lesions. All patients received antifungal therapies, and surgeries were performed in 13 (44.8%) patients. Patients who underwent surgery had numerically lower in-hospital mortality (15.4% vs. 31.3%, P=0.410). Involvement of unilateral multiple lesions was more common in patients who underwent surgeries (6/13 vs. 1/16, P=0.019). Patients who underwent surgery were more likely to have lobar and segmental bronchial involvement (13/13 vs. 9/16, P=0.007). A total of 15 patients underwent mNGS, 14 (93.3%) had positive results. Performing metagenomic next generation sequencing for diagnosis shortened the time from disease onset to diagnosis (log-rank P=0.014). Conclusion: Metagenomic next-generation sequencing aided early diagnosis. The patients who underwent surgery included unilateral multiple lesions and visualisation of endobronchial abnormalities on lobar or segmental bronchus in unilateral lung.

目的: 分析接受手术治疗与未手术的肺毛霉病患者的临床特征。 方法: 单中心回顾性研究。从中日友好医院电子病历系统中检索“肺毛霉病”,纳入 2016年7月—2022年6月的肺毛霉病患者29例,其中男19例,女10例,中位年龄49(47,67)岁。采用Mann-Whitney U检验、χ²检验、Kaplan-Meier曲线和log-rank检验比较组间差异。 结果: 肺毛霉病患者最常见的基础疾病是糖尿病(19例,65.5%),影像学表现以实变(25,86.2%)、结节或肿块(21例,72.4%)最常见,气管镜检查可见支气管狭窄(16例,55.2%)、真菌菌栓阻塞支气管开口(18例,62.1%)、支气管黏膜表面覆盖坏死物(19例,65.5%)等异常表现。所有患者均接受抗真菌药物治疗,13例(44.8%)患者接受手术治疗。患者是否手术由多学科团队(MDT)进行评估,16例未手术患者中有10例为双侧多发病灶、其中4例累及主支气管而无法切除,6例为单个肺叶内局限病灶。接受手术治疗的患者与未手术的患者相比,单侧肺多个病灶者(6/13比1/16,P=0.019)及叶、段支气管受累者(13/13比9/16,P=0.007)更常见。15例患者行宏基因组二代测序(mNGS),其中14例为阳性结果。进行mNGS检查缩短了从发病到诊断的时间(log-rank P=0.014)。接受手术治疗的患者院内病死率较低,但差异无统计学意义(2/13比5/16,P=0.410)。 结论: mNGS有助于肺毛霉病早期诊断。接受手术治疗患者的特征包括单侧多发病灶和支气管镜检叶、段支气管黏膜病变。.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use
  • Female
  • Humans
  • Lung Diseases, Fungal* / diagnosis
  • Lung Diseases, Fungal* / drug therapy
  • Lung Diseases, Fungal* / microbiology
  • Male
  • Middle Aged
  • Mucormycosis* / diagnosis
  • Mucormycosis* / therapy
  • Retrospective Studies

Substances

  • Antifungal Agents